News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website


Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 The virtual trial they are talking about is the next generation of our virtual trial registry.  It takes the giant leap into offering ideas for treatment options.  Our program never suggested anything - just observed what patients did and the outcome.  This new program will evaluate each patient and come up with ideas for treatment options that fit their specific profile.

Disclaimer:  I own stock in this company and am a consultant for it.


Posted on: 06/11/2019

Oncology Expert Keith T. Flaherty, MD Named Chairman of xCures Scientific Advisory Board

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740